Entrada Therapeutics, Inc. (TRDA)
13.88
+0.73
(+5.55%)
USD |
NASDAQ |
Apr 06, 16:00
13.90
+0.02
(+0.14%)
After-Hours: 05:04
Entrada Therapeutics SG&A Expense (TTM) : 41.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 29.83M |
| EyePoint Plc | 51.70M |
| Repligen Corp. | 290.51M |
| Vertex Pharmaceuticals, Inc. | 1.753B |
| Arcutis Biotherapeutics, Inc. | 274.55M |